January 10, 2025 - 04:50

For the fourth consecutive week, mortgage rates have climbed, inching closer to the 7% threshold. This rise follows an increase in 10-year Treasury yields, which typically reflect the trends in mortgage rates. Recent economic data released this week has indicated persistent inflation and a significant number of job openings, contributing to the upward pressure on interest rates.
The implications of these rising mortgage rates are significant for homebuyers and the housing market at large. Higher rates can lead to increased monthly payments, making home ownership less accessible for many potential buyers. As the cost of borrowing rises, some experts anticipate a slowdown in housing demand, which could impact home prices.
With inflation remaining a concern for policymakers, the trajectory of mortgage rates will likely continue to be influenced by economic indicators. Homebuyers and industry stakeholders are closely monitoring these developments as they navigate a challenging financial landscape.
February 26, 2026 - 06:37
Pathward Financial Stockholders Re-Elect Directors, Back Say-on-Pay and KPMG at 2026 AGMPathward Financial, Inc. concluded its 2026 Annual Meeting of Stockholders on February 24, with shareholders casting decisive votes on several critical governance matters. The meeting, chaired by...
February 25, 2026 - 22:04
New Retirement Savings Proposal Aims to Expand Worker AccessA new initiative announced by the White House seeks to create retirement savings opportunities for millions of private-sector employees currently lacking access to employer-sponsored plans like 401...
February 25, 2026 - 09:51
A Look At Synchrony Financial (SYF) Valuation After Recent Share Price PullbackSynchrony Financial (SYF) has captured investor focus as its recent share price movement prompts a fresh look at the company`s valuation. The stock recently saw a single-day gain of 2.7%, closing...
February 24, 2026 - 19:13
ADOCIA Reports Fourth Quarter 2025 Financial Results and Provides a Business UpdateLYON, France, February 24, 2026 -- Adocia, a clinical-stage biopharmaceutical company, has announced its financial results for the fourth quarter ending December 31, 2025, alongside a comprehensive...